KWALITY PHARMACEUTICALS Financial Statement Analysis
|
||
The Revenues of KWALITY PHARMACEUTICALS have decreased by -44.97% YoY .
The Earnings Per Share (EPS) of KWALITY PHARMACEUTICALS has decreased by -83.86 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
KWALITY PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 539997]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹251 Cr | ₹456 Cr | ₹262 Cr | ₹139 Cr | ₹166 Cr |
Expenses | ₹190 Cr | ₹285 Cr | ₹233 Cr | ₹125 Cr | ₹151 Cr |
Operating Profit (Excl OI) | ₹61 Cr | ₹172 Cr | ₹29 Cr | ₹14 Cr | ₹16 Cr |
Other Income | ₹2.94 Cr | ₹3.51 Cr | ₹1.59 Cr | ₹3.66 Cr | ₹0.61 Cr |
Interest | ₹6.61 Cr | ₹2.92 Cr | ₹2.68 Cr | ₹2.53 Cr | ₹2.29 Cr |
Depreciation | ₹15 Cr | ₹11 Cr | ₹6.49 Cr | ₹4.43 Cr | ₹3.12 Cr |
Profit Before Tax | ₹26 Cr | ₹162 Cr | ₹21 Cr | ₹11 Cr | ₹11 Cr |
Profit After Tax | ₹19 Cr | ₹120 Cr | ₹15 Cr | ₹8.21 Cr | ₹7.56 Cr |
Consolidated Net Profit | ₹19 Cr | ₹120 Cr | ₹15 Cr | ₹8.32 Cr | ₹7.55 Cr |
Earnings Per Share (Rs) | ₹18.67 | ₹115.64 | ₹14.60 | ₹8.02 | ₹7.28 |
PAT Margin (%) | 7.68 | 26.29 | 5.68 | 5.89 | 4.54 |
ROE(%) | 10.15 | 99.66 | 28.21 | 20.10 | 23.13 |
ROCE(%) | 12.06 | 95.32 | 26.36 | 18.49 | 21.91 |
Total Debt/Equity(x) | 0.45 | 0.35 | 0.68 | 0.77 | 0.79 |
Key Financials |
||
Market Cap | : | ₹ 513.2 Cr |
Revenue (TTM) | : | ₹ 284.0 Cr |
Net Profit(TTM) | : | ₹ 11.9 Cr |
EPS (TTM) | : | ₹ 11.4 |
P/E (TTM) | : | 43.1 |
Industry Peers & Returns | 1W | 1M | 1Y |
KWALITY PHARMACEUTICALS | -2.7% | 14.9% | 35.6% |
SUN PHARMACEUTICAL INDUSTRIES | 0.3% | -7.5% | 53.9% |
CIPLA | 1.1% | -4.8% | 56.4% |
DR REDDYS LABORATORIES | 1.6% | 1.6% | 27.6% |
ZYDUS LIFESCIENCES | 5.2% | -0.2% | 90.1% |
DIVIS LABORATORIES | -1.9% | 10.7% | 21.4% |
MANKIND PHARMA | -2.3% | 0.1% | NA |
TORRENT PHARMACEUTICALS | 1.6% | 2% | 61.8% |
LUPIN | 2.4% | 2% | 132.5% |
KWALITY PHARMACEUTICALS Revenues
[BOM: 539997]
Y-o-Y | -44.97 % |
5 Yr CAGR | 10.84 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹251 Cr | -44.97 | |
Mar2022 | ₹456 Cr | 74.11 | |
Mar2021 | ₹262 Cr | 88.10 | |
Mar2020 | ₹139 Cr | -16.23 | |
Mar2019 | ₹166 Cr | - |
KWALITY PHARMACEUTICALS Operating Profit
[BOM: 539997]
Y-o-Y | -64.62 % |
5 Yr CAGR | 40.21 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹61 Cr | -64.62 | |
Mar2022 | ₹172 Cr | 494.81 | |
Mar2021 | ₹29 Cr | 103.01 | |
Mar2020 | ₹14 Cr | -9.54 | |
Mar2019 | ₹16 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -35.72 % |
5 Yr CAGR | 26.49 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 24.19% | -35.72 | |
Mar2022 | 37.63% | 241.78 | |
Mar2021 | 11.01% | 7.84 | |
Mar2020 | 10.21% | 8.04 | |
Mar2019 | 9.45% | - |
KWALITY PHARMACEUTICALS Profit After Tax
[BOM: 539997]
Y-o-Y | -83.85 % |
5 Yr CAGR | 26.56 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹19 Cr | -83.85 | |
Mar2022 | ₹120 Cr | 692.23 | |
Mar2021 | ₹15 Cr | 82.11 | |
Mar2020 | ₹8.32 Cr | 10.13 | |
Mar2019 | ₹7.55 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -70.79 % |
5 Yr CAGR | 14.05 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 7.68 % | -70.79 | |
Mar2022 | 26.29 % | 362.85 | |
Mar2021 | 5.68 % | -3.57 | |
Mar2020 | 5.89 % | 29.74 | |
Mar2019 | 4.54 % | - |
KWALITY PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 539997]
Y-o-Y | -83.86 % |
5 Yr CAGR | 26.55 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹19 | -83.86 | |
Mar2022 | ₹116 | 692.05 | |
Mar2021 | ₹15 | 82.04 | |
Mar2020 | ₹8.02 | 10.16 | |
Mar2019 | ₹7.28 | - |
KWALITY PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 539997]
Y-o-Y | -87.35 % |
5 Yr CAGR | -13.87 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 12.06% | -87.35 | |
Mar2022 | 95.32% | 261.61 | |
Mar2021 | 26.36% | 42.56 | |
Mar2020 | 18.49% | -15.61 | |
Mar2019 | 21.91% | - |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Current Share Price | : | ₹493.5 |
Current MarketCap | : | ₹ 513.2 Cr |
Updated EOD on | : | May 03,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | -2.7% |
14.9% |
35.6% |
SENSEX | -0.6% |
0.3% |
21.8% |
KWALITY PHARMACEUTICALS related INDICES
You may also like the below Video Courses
FAQ about KWALITY PHARMACEUTICALS Financials
How the annual revenues of KWALITY PHARMACEUTICALS have changed ?
The Revenues of KWALITY PHARMACEUTICALS have decreased by -44.97% YoY .
How the Earnings per Share (EPS) of KWALITY PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of KWALITY PHARMACEUTICALS has decreased by -83.86 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs